NEWHALL CHARLES W III sold 2.7% of their position (3.59K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $161.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/29/2025ACC: 0001005544-25-000008
Director
Since Feb 2026
-3.59K
Net shares
Net seller
$161.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.59K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.59K
Price / share
$45.01
Trade value
$161.50K
% of position
2.7%
8/27/2025
133.23K→129.64K
Total
Net shares
−3.59K
Net value
-$161.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/27/2025 | S · Sale | −3.59K | $45.01 | $161.50K | 2.7% | 133.23K | 129.64K |
| Total | −3.59K | -$161.50K | ||||||
Derivative Transactions0
No derivative transactions reported